QA: Amicus Therapeutics INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2024_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 483,061,000
1 IntangibleAssetsNetIncludingGoodwill 218,287,000
2 PropertyPlantAndEquipmentNet 31,667,000
3 remainder_Assets 44,865,000
4 LiabilitiesCurrent 167,689,000
5 LiabilitiesNoncurrent 62,159,000
6 remainder_Liabilities 387,858,000
7 CostOfGoodsAndServicesSold 35,691,436
8 SellingGeneralAndAdministrativeExpense 362,643,544
9 ResearchAndDevelopmentExpense 84,132,421
10 remainder_Expenses 57,601,777
11 remainder_Revenues 412,539,676
12 remainder_NetIncome -12,551,370
13 remainder_ComprehensiveNetIncome -16,961,055
  yvar yval
0 Assets 777,880,000
1 Liabilities 617,706,000
2 Expenses 540,069,178
3 Revenues 412,539,676
4 StockholdersEquity 160,174,000
5 NetIncome -140,080,872
6 ComprehensiveNetIncome -148,561,400
7 BaseVar 1,188,853,640
8 EconomicCapitalRatiobeforeLimitedLiability 0.288
9 EconomicCapitalRatio 1.69

Edgar->Model Mapping

Feature Distribution

Change over Time